Pooled nucleic acid testing to identify antiretroviral treatment failure during HIV infection in Seoul, South Korea

References

• Bagnarelli P, Menzo S, Valenza A, Paolucci S, Petroni S, Scalise G, et al. Quantitative molecular monitoring of human immunodeficiency virus type 1 activity during therapy with specific antiretroviral compounds. J Clin Microbiol 1995; 33:16–23.
   PubMedGoogle Scholar
• Cook J, Dasbach E, Coplan P, Markson L, Yin D, Meibohm A, et al. Modeling the long-term outcomes and costs of HIV antiretroviral therapy using HIV RNA levels: application to a clinical trial. AIDS Res Hum Retroviruses 1999;15: 499–508.
   PubMed Web of Science ®Google Scholar
• Katzenstein DA, Holodniy M. HIV viral load quantification, HIV resistance, and antiretroviral therapy. AIDS Clin Rev 1995:277–303.
   Google Scholar
• Little SJ, Holte S, Routy JP, Daar ES, Markowitz M, Collier AC, et al. Antiretroviral-drug resistance among patients recently infected with HIV. N Engl J Med 2002; 347:385–94.
   PubMed Web of Science ®Google Scholar
• Bendavid E, Young SD, Katzenstein DA, Bayoumi AM, Sanders GD, Owens DK. Cost-effectiveness of HIV monitoring strategies in resource-limited settings: a southern African analysis. Arch Intern Med 2008;168:1910–8.
   PubMedGoogle Scholar
• Calmy A, Ford N, Hirschel B, Reynolds SJ, Lynen L, Goemaere E, et al. HIV viral load monitoring in resource-limited regions: optional or necessary?Clin Infect Dis 2007;44:128–34.
   PubMed Web of Science ®Google Scholar
• Phillips AN, Pillay D, Miners AH, Bennett DE, Gilks CF, Lundgren JD. Outcomes from monitoring of patients on antiretroviral therapy in resource-limited settings with viral load, CD4 cell count, or clinical observation alone: a computer simulation model. Lancet 2008;371:1443–51.
   PubMed Web of Science ®Google Scholar
• Schooley RT. Viral load testing in resource-limited settings. Clin Infect Dis 2007;44:139–40.
   PubMedGoogle Scholar
• Colebunders R, Moses KR, Laurence J, Shihab HM, Semitala F, Lutwama F, et al. A new model to monitor the virological efficacy of antiretroviral treatment in resource-poor countries. Lancet Infect Dis 2006;6:53–9.
   PubMed Web of Science ®Google Scholar
• Moore DM, Awor A, Downing R, Kaplan J, Montaner JS, Hancock J, et al. CD4 + T-cell count monitoring does not accurately identify HIV-infected adults with virologic failure receiving antiretroviral therapy. J Acquir Immune Defic Syndr 2008;49:477–84.
   PubMed Web of Science ®Google Scholar
• Mee P, Fielding KL, Charalambous S, Churchyard GJ, Grant AD. Evaluation of the WHO criteria for antiretroviral treatment failure among adults in South Africa. AIDS 2008; 22:1971–7.
   PubMed Web of Science ®Google Scholar
• Busch MP, Glynn SA, Stramer SL, Strong DM, Caglioti S, Wright DJ, et al. A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors. Transfusion 2005; 45:254–64.
   PubMed Web of Science ®Google Scholar
• Pilcher CD, Fiscus SA, Nguyen TQ, Foust E, Wolf L, Williams D, et al. Detection of acute infections during HIV testing in North Carolina. N Engl J Med 2005;352: 1873–83.
   PubMed Web of Science ®Google Scholar
• Pilcher CD, McPherson JT, Leone PA, Smurzynski M, Owen-O’Dowd J, Peace-Brewer AL, et al. Real-time, universal screening for acute HIV infection in a routine HIV counseling and testing population. JAMA 2002;288:216–21.
   PubMed Web of Science ®Google Scholar
• Smith DM, May SJ, Perez-Santiago J, Strain MC, Ignacio CC, Haubrich RH, et al. The use of pooled viral load testing to identify antiretroviral treatment failure. AIDS 2009; 23: 2151–8.
   PubMedGoogle Scholar
• Tilghman MW, Guerena DD, Licea A, Perez-Santiago J, Richman DD, May S, et al. Pooled nucleic acid testing to detect antiretroviral treatment failure in Mexico. J Acquir Immune Defic Syndr 2011;56:e70–4.
   PubMed Web of Science ®Google Scholar
• van Zyl GU, Preiser W, Potschka S, Lundershausen AT, Haubrich R, Smith D. Pooling strategies to reduce the cost of HIV-1 RNA load monitoring in a resource-limited setting. Clin Infect Dis 2011;52:264–70.
   PubMed Web of Science ®Google Scholar
• Lee JH, Hong KJ, Wang JS, Kim SS, Kee MK. Estimation of hospital-based HIV seroprevalence as a nationwide scale by novel method; 2002–2008 in Korea. BMC Public Health 2010;10:739.
   PubMedGoogle Scholar
• The World Bank. Data and statistics. Washington: World Bank. Available at: http://go.worldbank.org/K2CKM78CC0 (accessed 15 March 2013).
   Google Scholar
• May S, Gamst A, Haubrich R, Benson C, Smith DM. Pooled nucleic acid testing to identify antiretroviral treatment failure during HIV infection. J Acquir Immune Defic Syndr 2010;53:194–201.
   PubMed Web of Science ®Google Scholar
• Dorfman R. The detection of defective members of large populations. Annals of Mathematical Statistics 1943: 436–40.
   Google Scholar
• Klausner JD, Grant RM, Kent CK. Detection of acute HIV infections. N Engl J Med 2005;353:631–3; author reply 631–3.
   PubMedGoogle Scholar
• Pilcher CD, Price MA, Hoffman IF, Galvin S, Martinson FEA, Kazembe PN, et al. Frequent detection of acute primary HIV infection in men in Malawi. AIDS 2004;18:517–24.
   PubMed Web of Science ®Google Scholar
• Priddy FH, Pilcher CD, Moore RH, Tambe P, Park MN, Fiscus SA, et al. Detection of acute HIV infections in an urban HIV counseling and testing population in the United States. J Acquir Immune Defic Syndr 2007;44: 196–202.
   PubMedGoogle Scholar